Women with recurrent implantation failure (RIF). Patients with a limited number of high-quality embryos. Cases of unexplained infertility related to endometrial factors.

Book ERA Biopsy Test in Saudi Arabia | Lahalak Medical Platform

The ERA test increases IVF success rates by identifying the exact personalized window of implantation, ensuring optimal timing for embryo transfer and tailoring the treatment protocol to each patient's unique biological clock.

Scientific name: Endometrial Receptivity Array (ERA) Biopsy

A molecular diagnostic biopsy that analyzes gene expression to determine the personalized window of implantation (WOI) for IVF patients, significantly improving embryo transfer success rates.

Endometrial Receptivity Array (ERA) Biopsy - Pinpoint Your Perfect Implantation Window

Service type Diagnostic Biopsy

Duration 15-20 minutes

Fasting Fasting is not required

Included Services

Clinical biopsy procedure
Molecular analysis of 248 genes
Detailed WOI report

Medical Service Information

Purpose of the Procedure

Pinpoint the exact time the endometrium is ready for embryo implantation.
Increase pregnancy success rates in IVF cycles.
Minimize embryo loss caused by suboptimal timing.

Target Groups

Women with recurrent implantation failure (RIF).
Patients with a limited number of high-quality embryos.
Cases of unexplained infertility related to endometrial factors.

Result Interpretation

Receptive: The current timing is ideal for embryo transfer.
Non-receptive: Indicates a shift is needed (Pre-receptive or Post-receptive) for the transfer window.